Metabolic activation of retronecine and retronecine N-oxide

Abstract

We have previously reported that metabolism of a series of pyrrolizidine alkaloids in vitro and in vivo generated a set of (+/−)6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP)-derived DNA adducts. It has also been shown that the levels of the DHP-derived DNA adduct formation correlated closely with the tumorigenic potencies of the mice fed with different doses of riddelliine. Retronecine is the necine base and the structurally smallest chemical of the retronecine-type pyrrolizidine alkaloids. Although it has been reported that microsomal metabolism of retronecine generated DHP as a metabolite, it was yet not known whether metabolism of retronecine in vivo could generate DHP-derived DNA adducts and if formed, whether or not the levels of DNA adducts were comparable with those formed from the other tumorigenic retronecine-type pyrrolizidine alkaloids, such as riddelliine, retrorsine, and monocrotaline. In this investigation, the in-vitro and in-vivo metabolic activation of retronecine was studied. Rat liver microsomal metabolism of retronecine in the presence of calf thymus DNA resulted in the formation of a set of DHP–DNA adducts. The metabolism of retronecine N-oxide under similar conditions also formed the similar set of DHP–DNA adducts. The level of DNA adducts from retronecine was enhanced when metabolism by liver microsomes from phenobarbital (PB)-induced rats were used. The DHP–DNA adducts were also found in the liver DNA of female F344 rats treated with retronecine or retronecine N-oxide. The highest level of the total DHP–DNA adducts was found in liver DNA from the rats treated with dehydroretronecine (DHR). The order of the levels of DNA adducts in the liver DNA samples from rats treated with various pyrrolizidine alkaloids was: DHR > riddelliine > riddelliine N-oxide >> retronecine > retronecine N-oxide. The results indicate that 1) retronecine can be metabolized to form DHP by rat liver microsomal enzymes and interacts with DNA to produce DHP–DNA adducts and 2) retronecine N-oxide undergoes the biotransformation to the parent compound, retronecine. The results from this and our previous findings strongly suggest that formation of DHP–DNA adducts may be a potential biomarker for pyrrolizidine alkaloid carcinogenesis.

Keywords

DNA adduct pyrollizidine alkaloid retronecine retronecine N-oxide

Get full access to this article

View all access options for this article.

References

Betz JM Eppley RM Taylor WC Andrzejewski D (1994) Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.). J Pharm Sci 83: 649–653.

Byron J (1998) Pyrrolizidine alkaloids in eggs; new alkaloid found in potatoes. Food Chem News 14: 6–7.

Chan PC Haseman JK Prejean JD Nyska A (2003) Toxicity and carcinogenicity of riddelliine in rats and mice. Toxicol Lett 144: 295–311.

Chou MW Yan J Nichols J Xia Q Beland FA Chan PC (2003a) Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice. Cancer Lett 193: 119–125.

Chou MW Wang Y-P Yan J Yang Y-C Beger R Williams LD (2003c) Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol Lett 145: 239–247.

Chou MW Wang B Von Tungeln LS Beland FA Fu PP (1987) Induction of rat hepatic cytochromes P-450 by environmental nitropolycyclic aromatic hydrocarbons. Biochem Pharmacol 36: 2449–2454.

Chou MW Yan J Williams L Xia Q Churchwell M Doerge DR (2003c) Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid, in vitro and in vivo. Chem Res Toxicol 16: 1130–1137.

Fu PP Xia Q Lin G Chou MW (2004) Pyrrolizidine alkaloids—genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36: 1–55.

Huxtable RJ (1980) Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States. Perspect Biol Med 24: 1–14.

10.

International Agency for Research in Cancer (IARC) (1976) Pyrrolizidine alkaloids. In: IARC Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man—Some Naturally Occurring Substance, vol. 10. Lyon, France: International Agency for Research on Cancer, pp. 265–342.

11.

Mattocks AR (1986) Chemistry and Toxicology of Pyrrolizidine Alkaloids. New York: Academic Press.

12.

Mattocks AR Cabral JR (1982) Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues. Cancer Lett 17: 61–66.

13.

Molyneux JO Cooke MP King RR Mohamed PA (1990) Pyrrolizidine alkaloids in milk; thresholds of toxication. Vet Hum Toxicol 32: 94–103.

14.

Prakash AS Pereira TN Reilly PE Seawright AA (1999) Pyrrolizidine alkaloids in human diet. Mutat Res 443: 53–67.

15.

Schoental R Cavanagh JB (1972) Brain and spinal cord tumors in rats treated with pyrrolizidine alkaloids. J Natl Cancer Inst 49: 665–671.

16.

Schoental R Head MA Oeacook PR (1954) Senecio alkaloids: primary liver tumors in rats as a result of treatment with (1) a mixture of alkaloids from S. Jacobaea Lin.; (2) retrorsine; (3) isatidine. Br J Cancer 8: 458–465.

17.

Stegelmeier BL Edgar JA Colegate SM Gardner DR Schoch TK (1999) Pyrrolizidine alkaloid plant, metabolism and toxicity. J Nat Toxins 443: 53–67.

18.

Wang Y-P Fu PP Chou MW (2005a) Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adducts formation in vivo. Int J Environ Res Public Health 2: 74–79.

19.

Wang Y-P Yan J Beger RD Fu PP Chou MW (2005b) Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo. Cancer Lett 226: 27–35.

20.

Wang Y-P Yan J Fu PP Chou MW (2005c) Human liver microsomal reduction of pyrrolizidine alkaloid N-oxide to form the corresponding carcinogenic parent alkaloid. Toxicol Lett 155: 411–420.

21.

Xia Q Chou MW Edgar JA Doerge DR Fu PP (2006) Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine. Cancer Lett 231: 138–145.

22.

Xia Q Chou MW Kadlubar FF Chan P-C Fu PP (2003) Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Chem Res Toxicol 16: 66–73.

23.

Xia Q Chou MW Lin G Fu PP (2004) Formation of DHP-derived DNA adducts from metabolic activation of clivorine, a presentative otonecine-type pyrrolizidine alkaloid, and Ligularia hodgsonnii hook plant extract. Chem Res Toxicol 17: 702–708.

24.

Yang Y-C Yan J Churchwell M Beger R Chan P-C Doerge DR (2001a) Development of a 32P-postlabeling/HPLC method for detection of dehydroretronesine-derived DNA adducts in vitro and in vivo. Chem Res Toxicol 14: 91–100.

25.

Yang Y-C Yan J Doerge DR Chan P-C Fu PP Chou MW (2001b) Metabolic activation of the tumorigenic pyrrolizidine alkalois, riddelliine, leading to DNA adduct formation in vivo. Chem Res Toxicol 14: 101–109.

Metabolic activation of retronecine and retronecine N-oxide – formation of DHP-derived DNA adducts

Abstract

Keywords

Get full access to this article

References